Conservative management of CIN2: National Audit of British Society for Colposcopy and Cervical Pathology members’ opinion
- 6 December 2017
- journal article
- research article
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 38 (3) , 388-394
Abstract
There is no doubt that organised cervical screening programmes have significantly reduced the rates of cervical cancer by detection and treatment of high-grade cervical intraepithelial neoplasia (CIN2, CIN3). National UK guidelines do not differentiate between CIN2 and CIN3 as separate entities and recommend treatment for both, although a degree of uncertainty exists regarding the natural history of CIN2. This national survey of British Society for Colposcopy and Cervical Pathology members aimed to assess attitudes towards conservative management (CM) of CIN2 in the UK and identify potential selection criteria. In total, 511 members responded (response rate 32%); 55.6% offered CM for selective cases; 12.4% for all cases; 16.4% had formal guidelines. Most agreed age group was >40yrs (83%), HPV 16/18 positive (51.4%), smoking (60%), immuno-compromise (74.2%), and large lesion size (80.8%) were relative contraindications for CM. 75.9% favoured six-monthly monitoring, with 80.2% preferring excisional treatment for persistent high-grade disease. Many UK colposcopists manage CIN2 conservatively without formal guidelines. Potential selection criteria should be investigated by a multicentre study.Keywords
This publication has 31 references indexed in Scilit:
- Cytological screening for cervical cancer preventionBest Practice & Research Clinical Obstetrics & Gynaecology, 2012
- Outcome of expectant management of cervical intraepithelial neoplasia grade 2 in women followed for 12 monthsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- A Comparison of Loop Electrosurgical Excision Procedures Between Human Immunodeficiency Virus-Seropositive and -Seronegative WomenJournal of Lower Genital Tract Disease, 2011
- Comparative evaluation of nm23 and p16 expression as biomarkers of high-risk human papillomavirus infection and cervical intraepithelial neoplasia 2+ lesions of the uterine cervixHistopathology, 2010
- Using Biomarkers as Objective Standards in the Diagnosis of Cervical BiopsiesAmerican Journal of Surgical Pathology, 2010
- Heterogeneity in CIN3 diagnosisThe Lancet Oncology, 2008
- Why CIN3 and CIN2 should be distinguished on histological reportsCytopathology, 2008
- 2006 consensus guidelines for the management of women with abnormal cervical cancer screening testsAmerican Journal of Obstetrics and Gynecology, 2007
- Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomesAmerican Journal of Obstetrics and Gynecology, 2007
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993